We develop relationships with referring clinicians, not tourism groups, to achieve sustainable, mutually beneficial referral networks.
The “destination medicine” or “medical tourism” market has been valued at $40 billion, with continued significant growth. Depending on the specific regulatory environment and regenerative medicine protocols offered, individuals travelling from other regions may represent a significant portion of an RMCE’s patient flow.
In developing medical destination opportunities, Regen Med works with leading referring hospitals and physicians to ensure their participation in pre- and post-therapy consults. This continuity of patient care, easily achievable with multi-language inCytes™ observation protocols, is to the advantage of patients and referring HCP’s. In appropriate cases, Regen Med can work with an RMCE in developing medical destination patient flow by organizing events and other educational settings in the referring market with respected local medical institutions.